Schedule 13D ownership disclosure
MapLight Therapeutics Inc
Voting Common Stock, par value $0.0001 per share · CUSIP: 56565P103
Event date: 2025-10-28
- Filing-level shares
- 3,686,622.00
- Percent of class
- 8.4%
- Novo Holdings A/SReported CIK 0001388325
Shares: 3,686,622.00 · Class: 8.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001388325-25-000021
- Form type
- SCHEDULE 13D
- Filer
- MapLight Therapeutics, Inc.
- CIK
- CIK 1770069
- Filed
- Nov 04, 2025
- Reporting period
- Oct 28, 2025
- Description
- Schedule 13D beneficial ownership